B Cell Lymphoma
Major finding: Among evaluable patient treated with chimeric antigen receptor expressing T cells, 12 of 13 had complete or partial remissions, and...
Major finding: Overall survival was 97% in adults treated with DA-EPOCH-R, and event-free survival was 93%.Data source: A phase II, prospective...
Major Finding: Interim 18FDG-PET had a PPV of 58% and a NPV of 77%.
Major Finding: The 2-year overall survival rates were 81% in the R-CHOP-21 arm, and 83% in the R-CHOP-14 arm (log rank P = .70).